Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41385642.
- Also identified by DOI 10.1126/sciadv.adw1289 and PMC identifier 12700201.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The histone methyltransferase DOT1L is emerging as a central epigenetic regulator in immune cells. Loss of DOT1L during development of CD8 T cells in vivo leads to gain of memory characteristics but has also been reported to compromise CD8 T cell viability and antitumor reactivity. Here, we determined the cell-intrinsic role of DOT1L in mature mouse CD8 T cells. After conditional deletion of <i>Dot1L</i> in vitro, CD8 T cells retained in vivo proliferative capacity and antitumor reactivity. Moreover, <i>Dot1L</i> knockout CD8 T cells showed increased antigen-specific cytotoxicity toward tumor cells in vitro. Mechanistically, loss of DOT1L resulted in an altered cell state with loss of T cell and gain of innate-like features. These transcriptional changes were mediated by loss of DOT1L methyltransferase activity in a dose-dependent manner. Our findings show that in mature CD8 T cells, ablation of DOT1L activity is well tolerated and reprograms them to gain innate-like memory cell characteristics and enhance intrinsic cytotoxic capacity.
Medical subject headings
- Histone-Lysine N-Methyltransferase
- CD8-Positive T-Lymphocytes
- Cytotoxicity, Immunologic
- Methyltransferases